awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35888386-333CF298-0D6A-42F7-A4DC-D5B0F682E578
Q35888386-333CF298-0D6A-42F7-A4DC-D5B0F682E578
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35888386-333CF298-0D6A-42F7-A4DC-D5B0F682E578
Pharmacokinetics, lymph node uptake, and mechanistic PK model of near-infrared dye-labeled bevacizumab after IV and SC administration in mice.
P2860
Q35888386-333CF298-0D6A-42F7-A4DC-D5B0F682E578
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35888386-333CF298-0D6A-42F7-A4DC-D5B0F682E578
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5c4c6f50ea495b9b8ba40526a60822651be40665
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.